Skip to main content
Isabella Glitza, MD, Oncology, Houston, TX

Isabella Claudia Glitza MD


Physician

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Dr. Glitza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2007 - 2010
  • Ruprecht Karl University Faculty of Medicine
    Ruprecht Karl University Faculty of MedicineClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • TX State Medical License
    TX State Medical License 2011 - 2026
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • PA State Medical License
    PA State Medical License 2007 - 2012
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Janice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
  • Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Scott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
  • Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Richard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
  • Join now to see all

Press Mentions

  • Stage IV Melanoma Survivor: Immunotherapy Clinical Trial Gave Me My Life Back
    Stage IV Melanoma Survivor: Immunotherapy Clinical Trial Gave Me My Life BackJune 12th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: